A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/21/2006	US7138234 Gene involved in CADASIL, method of diagnosis and therapeutic application
11/21/2006	US7138149 aminosaccharide, a ginger component, and an enzyme such as bromelain
11/21/2006	US7138146 Acrochordon alleviation
11/21/2006	US7138141 Atomizing proteins, nucleic acids, or polysaccharides to form microstructure drops used as inhalants; drug delivery
11/21/2006	US7138136 Biocompatible particles between 0.1 and 1.0 microns in diameter, that are loaded with one or more drugs and which are crosslinked together to form agglomerates
11/21/2006	US7138127 Clostridial toxin derivatives and methods for treating pain
11/21/2006	US7138125 Polypeptide for prevention, therapy of bacteria infections; gramnegative bacteria; therapy for reduced lactation in animals
11/21/2006	US7138124 Lipopolysaccharides; forming antibodies; isolation exterior membrane polypeptide
11/21/2006	US7138123 Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
11/21/2006	US7138119 Compositions and methods for inhibition of HIV-1 infection
11/21/2006	US7138118 Methods of treating rheumatoid arthritis with anti-TNF antibodies
11/21/2006	US7138115 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease
11/21/2006	US7138114 Pharmaceutical compositions of fibrinolytic agent
11/21/2006	US7138113 Glycoprotein matrix compositions and methods related thereto
11/21/2006	US7138103 Completitive binding
11/21/2006	US7137989 Method, instruments, and kit for autologous transplantation
11/21/2006	CA2478621C Botulinum toxin pharmaceutical compositions
11/21/2006	CA2433386C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
11/21/2006	CA2253736C Antimicrobial treatment for herpes simplex virus and other infectious diseases
11/21/2006	CA2078003C Tumor killing effects of enterotoxins and related compounds
11/17/2006	CA2549902A1 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
11/16/2006	WO2006122327A2 Milk fat globule epidermal growth factor-factor viii and sepsis
11/16/2006	WO2006122205A2 Conus californicus neurotoxins
11/16/2006	WO2006122187A2 Treating and evaluating inflammatory disorders
11/16/2006	WO2006122178A2 A method for modulating hla class ii tumor cell surface expression with a cytokine mixture
11/16/2006	WO2006122162A2 Use of peptides derived from the growth factor amp-18 for the treatment of mucositis
11/16/2006	WO2006122139A2 Use of tfpi to treat severe bacterial infections
11/16/2006	WO2006122127A1 Compositions for administering rnaiii-inhibiting peptides
11/16/2006	WO2006122123A2 Methods of alleviating disorders and their associated pain
11/16/2006	WO2006121904A1 Glucose-dependent insulinotropic polypeptide (gip) receptor agonists and their pharmacological methods of use
11/16/2006	WO2006121860A2 Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
11/16/2006	WO2006121857A2 Unsolvated and host-guest solvated crystalline forms of (2e,4s)-4-[(n-{[(2r)-1-isopropylpiperidin-2-yl]-carbonyl}-3-methyl-l-valyl)(methyl)amino]-2,5-dimethylhex-2-enoic acid and their pharmaceutical uses
11/16/2006	WO2006121588A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
11/16/2006	WO2006121507A1 Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria
11/16/2006	WO2006121199A1 Lipid liposome composition
11/16/2006	WO2006120974A1 Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage
11/16/2006	WO2006120914A1 Polymeric derivative of cytidine metabolic antagonist
11/16/2006	WO2006120678A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
11/16/2006	WO2006120580A2 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/16/2006	WO2006120226A1 Stabilizer molecule-depleted albumin solution
11/16/2006	WO2006120160A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases
11/16/2006	WO2006120019A2 Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions
11/16/2006	WO2006119965A2 Growth factor mutants with altered biological attributes
11/16/2006	WO2006119767A2 Neuritogenic peptides
11/16/2006	WO2006119527A2 Melanoma-associated endogenous retrovirus (merv) derived peptide sequences and their therapeutic/ diagnostic use
11/16/2006	WO2006091332A3 Intranasal administration of active agents to the central nervous system
11/16/2006	WO2006060753A3 Diagnosis and treatment of alzheimer's disease
11/16/2006	WO2006051103A3 Stable formulations of peptides
11/16/2006	WO2006050837A3 Ophthalmic emulsions containing an immunosuppressive agent
11/16/2006	WO2006034395A3 Methods and compositions relating to mannuronic acid specific binding peptides
11/16/2006	WO2006005706A8 Combination therapy for preventing or treating alzheimer's disease, and kit therefor
11/16/2006	WO2005110465A3 Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases
11/16/2006	WO2001057190A3 Novel nucleic acids and polypeptides
11/16/2006	US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006	US20060259988 Use of dg931 protein for treating diabetes, obesity and metabolic syndrome
11/16/2006	US20060259986 Truncated fragments of alpha-synuclein in Lewy Body Disease
11/16/2006	US20060258851 Hybird molecules having factor VII/VIIa activity
11/16/2006	US20060258843 altered biological persistence; modified botulinum light chain containing a tyrosine phosphorylation site located within the first 10 amino acids of the N-terminal of the modified light chain; for therapy of neuromuscular disorders, autonomic nervous system disorders and pain
11/16/2006	US20060258841 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258838 Preparation of somatostatin peptides
11/16/2006	US20060258744 Medicament for preventing and/or treating peripheral neuropathies
11/16/2006	US20060258738 Use of dronabinol for treatment of side effects of Hepatitis C therapy
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258629 Photodynamic therapy for ocular neovascularization
11/16/2006	US20060258606 Transforming growth factor-beta response element decoys and methods
11/16/2006	US20060258598 Alpha-keto carbonyl calpain inhibitors
11/16/2006	US20060258597 Antitumorigenic drug combination and dosing schedule
11/16/2006	US20060258596 Antimicrobial agents
11/16/2006	US20060258595 Apoptosis of rectum and prostate gland cancer
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006	US20060258593 Methods and compositions for the treatment of gastrointestinal disorders
11/16/2006	US20060258592 Materials and methods for regulating blood flow
11/16/2006	US20060258591 Compositions and methods of treating HIV infections
11/16/2006	US20060258590 Chimeric peptide: antagonist, endogeneous ligand binding to protein; therapy for metabolism disorders; obesity
11/16/2006	US20060258589 Methods for enhancing radiation therapy
11/16/2006	US20060258588 Compositions and methods for treating articular cartilage disorders
11/16/2006	US20060258587 Modified MscL protein channel
11/16/2006	US20060258586 Compositions and uses of secreted polypeptide, Zsig98
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060258584 Chimeric proteins with phosphatidylserine binding domains
11/16/2006	US20060258583 Anti-angiogenic peptides for treating or preventing endometriosis
11/16/2006	US20060258582 Method of treating myelodysplastic syndromes
11/16/2006	US20060258581 Methods and composition for derepressions of IAP-inhibited caspase
11/16/2006	US20060258580 Such as N-acyl/myristoyl-gamma-glucose-diaminopimelic acid dipeptides; for activation of nuclear factor kappa beta; for treatment of inflammatory diseases such as Crohn's disease and asthma; drug screening
11/16/2006	US20060258579 Administering after the onset of sepsis or septicemia an amount of fetuin effective to inhibit release of high mobility group proteins
11/16/2006	US20060258578 Pharmaceutical composition
11/16/2006	US20060258577 Antiviral agents for the treatment, control and prevention of infections by coronaviruses
11/16/2006	US20060258576 Gdnf-related neuropeptides
11/16/2006	US20060258575 Sustained-release microparticle preparation of human growth hormone and process for producing thereof
11/16/2006	US20060258574 Novel compositions and methods for the treatment of psoriasis
11/16/2006	US20060258573 Peptide anti-tumor agent
11/16/2006	US20060258572 Somatostatin-dopamine chimeric analogs
11/16/2006	US20060258571 Antibacterial ester macrocycles
11/16/2006	US20060258570 Decorin proteoglycan inhibitor of fibrinogen blood clotting
11/16/2006	US20060258568 Use of human chorionic gonadotropin in the treatment in the treatment of symptoms endometriosis
11/16/2006	US20060258567 Xcrf polynucleotides and polypeptides and uses thereof
11/16/2006	US20060258566 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/16/2006	US20060258565 Methods of inhibiting viral infection

1 ... 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 ... 3163